Acute Care of at-Risk Newborns

From WikiMD's WELLNESSPEDIA

Acute Care of at-Risk Newborns (also known as ACoRN) is a systematic approach to the initial stabilization and management of newborns who are at risk of requiring acute care immediately after birth. This approach is designed to provide a standardized method of care to ensure the best possible outcomes for these newborns.

Overview[edit]

The ACoRN process begins with the identification of newborns who are at risk. This includes newborns with preterm, low birth weight, birth asphyxia, congenital anomalies, and those who are ill or unstable at birth. Once these newborns are identified, they are immediately assessed and stabilized using a systematic approach.

Assessment and Stabilization[edit]

The initial assessment of at-risk newborns includes a rapid evaluation of their Apgar score, breathing, heart rate, color, and activity. This is followed by immediate stabilization, which may include airway management, breathing support, circulation support, and temperature control.

Management[edit]

After stabilization, the newborn is managed according to their specific needs. This may include ongoing support for breathing and circulation, NICU admission, and specific treatments for their condition.

Training[edit]

Training in ACoRN is provided to healthcare professionals who care for newborns at risk. This includes neonatologists, pediatricians, nurses, and respiratory therapists. The training includes both theoretical knowledge and practical skills.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.